Caroline Loew is the founder of Mural Oncology. Mural Oncology has raised $275M in total funding. Latest round: Seed. Backed by Alkermes. Based in Boston, MA.
Caroline J. Loew, Ph.D., is the Chief Executive Officer designate of Mural Oncology plc, a clinical-stage immuno-oncology company spun out from Alkermes in November 2024. She previously served as an executive at Bristol Myers Squibb (BMS) before taking on her new CEO role at Mural Oncology.
Full founder directory · Investor directory · Company funding database · Fundraising library